Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Androgens reduce THY1 in skin cells, leading to less fat, more fibrosis, and worse healing in males.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

TRH stimulates human hair growth and extends the hair growth phase.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Blocking LFA-1 prevents hair loss in mice.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

TGF-β2 helps yak hair follicles enter the regression phase, while HSP70 tries to prevent it.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

HPV8 E6 gene causes growth of certain skin stem cells.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Inhibiting TYK2 can restore hair growth in alopecia areata.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Polymeric nanoparticles show promise for treating skin diseases.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Liposomes improve drug delivery and reduce skin irritation in dermatology.